| 03/10/22 | 07:00:14 | 3 Oct 2022 | | Product rebranding as Tutivia™ |
| 07/09/22 | 07:00:03 | 7 Sept 2022 | | Half-year Report |
| 06/09/22 | 07:00:12 | 6 Sept 2022 | | Positive results for Clarava from validation study |
| 05/09/22 | 07:00:11 | 5 Sept 2022 | | Notice of Results |
| 02/09/22 | 16:41:17 | 2 Sept 2022 | | Second Price Monitoring Extn |
| 02/09/22 | 16:35:46 | 2 Sept 2022 | | Price Monitoring Extension |
| 27/06/22 | 15:17:18 | 27 Jun 2022 | | Result of AGM and voting results |
| 24/06/22 | 07:00:05 | 24 Jun 2022 | | Holding(s) in Company |
| 20/06/22 | 07:30:03 | 20 Jun 2022 | | Distribution of Verici Dx shares by EKF |
| 16/06/22 | 07:00:09 | 16 Jun 2022 | | Investor Presentation |
| 15/06/22 | 10:57:02 | 15 Jun 2022 | | CEO Video Interview |
| 14/06/22 | 09:00:02 | 14 Jun 2022 | | Further data from Tuteva™ validation study |
| 09/06/22 | 07:00:05 | 9 Jun 2022 | | Commercial Team Appointments |
| 25/05/22 | 12:00:07 | 25 May 2022 | | Posting of Annual Report & Accounts |
| 19/05/22 | 07:00:09 | 19 May 2022 | | Final Results |
| 12/05/22 | 07:00:08 | 12 May 2022 | | Results of Tuteva™ clinical validation study |
| 01/04/22 | 07:00:09 | 1 Apr 2022 | | Clinical Validation Study Update |
| 23/03/22 | 18:12:28 | 23 Mar 2022 | | Holding(s) in Company |
| 21/03/22 | 07:00:10 | 21 Mar 2022 | | Holding(s) in Company |
| 18/03/22 | 17:13:13 | 18 Mar 2022 | | Holding(s) in Company |
| 16/03/22 | 15:33:48 | 16 Mar 2022 | | Holding(s) in Company |
| 15/03/22 | 16:34:43 | 15 Mar 2022 | | Holding(s) in Company |
| 11/03/22 | 09:30:02 | 11 Mar 2022 | | Close of Subscription and Fundraise Update |
| 04/03/22 | 16:13:12 | 4 Mar 2022 | | Result of Fundraise |
| 04/03/22 | 12:20:07 | 4 Mar 2022 | | Close of Accelerated Bookbuild |
| 04/03/22 | 07:10:30 | 4 Mar 2022 | | Proposed Fundraise |
| 15/02/22 | 07:00:05 | 15 Feb 2022 | | Successful completion of analytical validation |
| 26/01/22 | 16:28:29 | 26 Jan 2022 | | Net Asset Value(s) |
| 14/01/22 | 07:00:04 | 14 Jan 2022 | | Investor Presentation |
| 12/01/22 | 14:00:18 | 12 Jan 2022 | | Progress and strategy update |
| 06/01/22 | 07:00:05 | 6 Jan 2022 | | Clarava™ and Tuteva™ complete testing requirements |
| 05/01/22 | 07:00:07 | 5 Jan 2022 | | Collaboration with Illumina |
| 04/01/22 | 07:00:12 | 4 Jan 2022 | | Grant of two CPT Codes by AMA |
| 17/12/21 | 13:19:46 | 17 Dec 2021 | | Holding(s) in Company |
| 08/11/21 | 07:00:09 | 8 Nov 2021 | | Launch of Barbara T. Murphy Endowed Lectureship |
| 01/11/21 | 07:00:14 | 1 Nov 2021 | | Launch of Career Development Research Grant |
| 13/09/21 | 07:01:07 | 13 Sept 2021 | | Lorenzo Gallon, MD, Appointed as Chair of S.A.B |
| 13/09/21 | 07:00:07 | 13 Sept 2021 | | Half-year Report |
| 06/09/21 | 07:00:07 | 6 Sept 2021 | | Notice of Results |
| 31/08/21 | 07:00:10 | 31 Aug 2021 | | Patient enrolment completed |
| 19/08/21 | 07:00:07 | 19 Aug 2021 | | Appointment of Non-executive Director |
